This study looked at nearly 4,000 COPD patients to identify which non-COPD medications may negatively affect lung function. This is important because it narrows down the medication candidates and therapeutic targets for other studies leading to new treatments or prevention methods for COPD. Dr. Barry Make is the principal investigator the Lung Association ACRC site located at National Jewish Health.
Join over 700,000 people who receive the latest news about lung health, including research, lung disease, air quality, quitting tobacco, inspiring stories and more!
Thank you! You will now receive email updates from the American Lung Association.